Send Inquiry

Request To Call Back

Apiban-2.5 mg Tablets

Get a Price/Quote

MOQ : 10 Boxes

Apiban-2.5 mg Tablets Specification

Pacakaging (Quantity Per Box)
30 tablets

Packaging Type
Blister pack

Dosage Form
Oral tablet

Salt Composition
Apixaban

Origin of Medicine
India

Brand Name
Apiban-2.5 mg

Life Span
36 months from manufacture

Indication
Atrial fibrillation, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)

Drug Type
Allopathic

Ingredients
Apixaban 2.5 mg

Physical Form
Tablet

Function
Anticoagulant (blood thinner)

Recommended For
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; prevention and treatment of DVT and PE

Dosage
As directed by physician

Dosage Guidelines
Take orally with or without food, exact dosage as prescribed

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C in a dry place, protect from light

Active Strength
2.5 mg

Side Effects
Bleeding, anemia, nausea

Prescription/Non Prescription
Prescription only

Contraindications
Active bleeding, severe hepatic impairment, hypersensitivity to apixaban

ATC Code
B01AF02

Shape
Round

Shelf Life After Opening
Keep in original packaging until use

Tablet Colour
Yellow

Regulatory Approval
WHO GMP, Indian FDA

Marketed For
Clinical and hospital supply

Apiban-2.5 mg Tablets Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
500 Boxes Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Apiban-2.5 mg Tablets

Apiban-2.5 mg Tablets stand out in the market as a highly acclaimed and top-notch anticoagulant, in demand among healthcare professionals. These yellow, round tablets contain the premium active strength of 2.5 mg Apixaban, tailored for adult patients requiring the prevention of stroke and systemic embolism associated with nonvalvular atrial fibrillation, as well as the prevention and treatment of DVT and PE. Each blister pack contains 30 top-drawer tablets, developed and manufactured under the rigorous standards of WHO GMP and Indian FDA. Scarce in availability due to high clinical demand, Apiban-2.5 mg is prescription-only and suitable for hospital and clinical settings.

Advantages and Versatile Applications

Apiban-2.5 mg Tablets offer remarkable efficacy for the prevention of stroke and systemic embolism, and are extensively used in hospital and clinical environments. These allopathic oral tablets serve not only in atrial fibrillation but also in managing DVT and PE. Their versatility is matched by their safety and precision, making them a preferred choice for physicians. Further, their suitability exclusively for adult use ensures targeted and effective therapy across a spectrum of anticoagulation needs.

Certification, Delivery, and Transportation Details

Certified under WHO GMP and Indian FDA regulatory guidelines, Apiban-2.5 mg Tablets meet the strictest quality benchmarks. The tablets are expertly packaged to be dispatched from reputable Indian FOB ports. With reliable transportation arrangements, the product typically arrives within a prompt delivery window, ensuring that bulk orders for suppliers, exporters, and wholesalers reach their destinations on time and in optimal condition.

FAQ's of Apiban-2.5 mg Tablets:

Q: How should Apiban-2.5 mg Tablets be administered?

A: Apiban-2.5 mg Tablets are taken orally, with or without food, exactly as directed by a physician. The prescribed dosage should always be followed to ensure optimal efficacy and safety.

Q: What are the main benefits of using Apiban-2.5 mg Tablets?

A: These tablets are acclaimed for their effectiveness in preventing stroke and systemic embolism in adults with nonvalvular atrial fibrillation, and for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Q: Where should Apiban-2.5 mg Tablets be stored after opening?

A: Apiban-2.5 mg Tablets should be stored below 30C in their original packaging, kept in a dry place, and protected from light to preserve their quality.

Q: When should the use of Apiban-2.5 mg Tablets be avoided?

A: The tablets are contraindicated in cases of active bleeding, severe hepatic impairment, or hypersensitivity to apixaban. Always consult a physician prior to use.

Q: What side effects may occur with Apiban-2.5 mg Tablets?

A: Commonly reported side effects include bleeding, anemia, and nausea. Patients should report any unusual symptoms to their healthcare provider immediately.

Q: What certifications ensure the quality of Apiban-2.5 mg Tablets?

A: These tablets are manufactured under strict WHO GMP and Indian FDA approvals, providing assurance of rigorous quality, safety, and efficacy standards.

Tell us about your requirement